Who
Cheryl R. Blanchard
Director
Company insider
Files Form 4 as: Director, Xilio Therapeutics; President, CEO, Director, Anika Therapeutics; Director, Vigil Neuroscience; Director, Dare Bioscience; Director, Neuronetics; Director, SeaSpine Holdings; Sr. VP, Chief Scientific Off., Zimmer Biomet Holdings.
In numbers
- Trades disclosed
- 164
- Buys
- 1
- Sells
- 4
- Bought
- $207K
- Sold
- $2.6M
- Companies
- 7
- Companies where not an officer
- 5
- First trade
- 18 Jan 2006
- Last trade
- 15 Apr 2026
- Last filed
- 16 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Apr 2026filed 16 Apr 2026 | XLO Xilio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 15 Apr 2026filed 16 Apr 2026 | XLO Xilio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —25,131 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code M | —25,131 | filing |
| 15 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code F | $172K12,104 at $14.20 | filing |
| 15 Mar 2026filed 17 Mar 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —25,131 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code M | —25,131 | filing |
| 15 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code F | $172K12,104 at $14.20 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code M | —24,519 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code A | —24,520 at $0.00 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code F | $209K14,728 at $14.20 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —24,519 at $0.00 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —24,519 at $0.00 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code M | —24,519 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code A | —24,520 at $0.00 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code F | $209K14,728 at $14.20 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code M | —20,001 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code F | $88K5,871 at $14.96 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —20,001 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ANIK Anika Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —20,001 at $0.00 | filing |
News
ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENTZBH · prnewswire.com · 13 Oct 2026Analyzing Anika Therapeutics (NASDAQ:ANIK) & ADMA Biologics (NASDAQ:ADMA)ANIK · dailypolitical.com · 13 Oct 2026Warsaw Library fundraiser Oct. 22 at Zimmer Biomet Center Lake PavilionZBH · 1073wrsw.com · 10 Oct 2026
0 headlines in the last 90 days name Cheryl R. Blanchard; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.